The global endoscopic hemostasis devices market size was valued at USD 2,066.92 million in 2024, growing at a CAGR of 3.6% during 2025–2034. The growth is driven by the favorable government initiatives and cancer screening programs.
The landscape of gastrointestinal care is rapidly evolving, driven by a surge in demand for minimally invasive procedures and sophisticated medical technologies. The broader endoscopic therapy devices market is experiencing significant momentum as healthcare providers seek safer, more efficient alternatives to traditional surgeries. This shift is closely tied to the expanding minimally invasive surgical devices market, which offers reduced recovery times, lower risk of complications, and enhanced patient comfort. A major catalyst for this transition is the escalating burden of digestive conditions, which directly fuels the gastrointestinal disorder treatment market. As dietary habits change and chronic conditions rise, the need for precise diagnostic and therapeutic interventions has never been more critical.
To support these complex procedures, the endoscopy accessories market has seen substantial innovation, providing clinicians with the specialized tools required for optimal outcomes. Manufacturers are heavily investing in next-generation solutions that offer improved efficacy and safety. For example, FUJIFILM India recently expanded its portfolio with the launch of the ClutchCutter and FlushKnife, designed to improve the effectiveness of endoscopic submucosal dissection (ESD) and mucosal resection (EMR). Furthermore, the advanced hemostasis technology market is benefiting from breakthroughs in noncontact powder sprays and thermal coagulation systems. In November 2024, NEXT BIOMEDICAL received MFDS approval for Nexpowder-S, an upgraded endoscopic hemostatic agent enhanced with sucralfate for peptic ulcers, significantly improving efficacy over its predecessor.
Read More @ https://www.polarismarketresearch.com/industry-analysis/endoscopic-hemostasis-devices-market
Additionally, for thermal and injection hemostasis, Boston Scientific’s Gold Probe and Injection Gold Probe catheters combine unique tip designs for effective coagulation and integrated irrigation, helping to reduce catheter exchanges and overall procedural time. Boston Scientific also offers the Speed and Superview Super 7 Multiple Band Ligator for efficient variceal band ligation, and the Interject Injection Therapy Needle Catheter for reliable injection in tortuous anatomy.
Regionally, while North America led the market in 2024, the Asia Pacific is emerging as the fastest-growing region, fueled by rising awareness of endoscopic interventions and increasing healthcare investments. As these advanced technologies become more widely adopted across global healthcare settings, they promise to deliver more patient-centric care and drive sustained market expansion in the coming decade.
More Trending Latest Reports By Polaris Market Research:
Electronic Health Records Market
Disposable Duodenoscope Market
Pharmacogenomics Technologies Market
Graphene-Enhanced Conductive Polymers Market
Comments